125 related articles for article (PubMed ID: 8427997)
1. Interleukin-11 acts as an autocrine growth factor for human megakaryoblastic cell lines.
Kobayashi S; Teramura M; Sugawara I; Oshimi K; Mizoguchi H
Blood; 1993 Feb; 81(4):889-93. PubMed ID: 8427997
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-3 is an autocrine growth factor of human megakaryoblasts, the DAMI and MEG-01 cells.
Chen YZ; Gu XF; Caen JP; Han ZC
Br J Haematol; 1994 Nov; 88(3):481-7. PubMed ID: 7819061
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines.
Liu RY; Fan C; Garcia R; Jove R; Zuckerman KS
Blood; 1999 Apr; 93(7):2369-79. PubMed ID: 10090948
[TBL] [Abstract][Full Text] [Related]
4. Growth and differentiation of a human megakaryoblastic cell line, CMK.
Komatsu N; Suda T; Moroi M; Tokuyama N; Sakata Y; Okada M; Nishida T; Hirai Y; Sato T; Fuse A
Blood; 1989 Jul; 74(1):42-8. PubMed ID: 2665839
[TBL] [Abstract][Full Text] [Related]
5. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 6, a possible autocrine growth and differentiation factor for the human megakaryocytic cell line, CMK.
Fuse A; Kakuda H; Shima Y; Van Damme J; Billiau A; Sato T
Br J Haematol; 1991 Jan; 77(1):32-6. PubMed ID: 1998594
[TBL] [Abstract][Full Text] [Related]
7. Gene-targeted specific inhibition of chronic myeloid leukemia cell growth by BCR-ABL antisense oligodeoxynucleotides.
Skórski T; Szczylik C; Malaguarnera L; Calabretta B
Folia Histochem Cytobiol; 1991; 29(3):85-9. PubMed ID: 1794439
[TBL] [Abstract][Full Text] [Related]
8. Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173.
Smetsers TF; Skorski T; van de Locht LT; Wessels HM; Pennings AH; de Witte T; Calabretta B; Mensink EJ
Leukemia; 1994 Jan; 8(1):129-40. PubMed ID: 8289478
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.
Mahon FX; Ripoche J; Pigeonnier V; Jazwiec B; Pigneux A; Moreau JF; Reiffers J
Exp Hematol; 1995 Dec; 23(14):1606-11. PubMed ID: 8542954
[TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.
Abe A; Emi N; Kato H; Adachi K; Murate T; Saga S; Ogura M; Kojima T; Tanimoto M; Morishita N
Leukemia; 1995 Feb; 9(2):341-9. PubMed ID: 7869773
[TBL] [Abstract][Full Text] [Related]
11. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
Wu AG; Joshi SS; Chan WC; Iversen PL; Jackson JD; Kessinger A; Pirruccello SJ; Sanger WG; Sharp JG; Verbik DJ
Leuk Lymphoma; 1995 Dec; 20(1-2):67-76. PubMed ID: 8750625
[TBL] [Abstract][Full Text] [Related]
12. Phosphorothioate BCR-ABL antisense oligonucleotides induce cell death, but fail to reduce cellular bcr-abl protein levels.
Smetsers TF; van de Locht LT; Pennings AH; Wessels HM; de Witte TM; Mensink EJ
Leukemia; 1995 Jan; 9(1):118-30. PubMed ID: 7845006
[TBL] [Abstract][Full Text] [Related]
13. Differentiation induction of blast cells in two cases of childhood acute megakaryoblastic leukemia in vitro by interleukin-3 and interleukin-6: an ultrastructural cytochemical study.
Miyauchi J; Sugita K; Okui M; Taguchi N; Clark SC; Shimizu K
J Cell Physiol; 1991 Sep; 148(3):404-13. PubMed ID: 1655816
[TBL] [Abstract][Full Text] [Related]
14. Retrovirally transduced antisense sequences stably suppress P210BCR-ABL expression and inhibit the proliferation of BCR/ABL-containing cell lines.
Martiat P; Lewalle P; Taj AS; Philippe M; Larondelle Y; Vaerman JL; Wildmann C; Goldman JM; Michaux JL
Blood; 1993 Jan; 81(2):502-9. PubMed ID: 8422466
[TBL] [Abstract][Full Text] [Related]
15. Human leukemia cell lines bind basic fibroblast growth factor (FGF) on FGF receptors and heparan sulfates: downmodulation of FGF receptors by phorbol ester.
Liuzzo JP; Moscatelli D
Blood; 1996 Jan; 87(1):245-55. PubMed ID: 8547648
[TBL] [Abstract][Full Text] [Related]
16. [Megakaryocytic leukemia cell lines and megakaryocytic leukemia].
Ryo R; Yoshida A; Yamaguchi N
Rinsho Byori; 1990 May; 38(5):514-23. PubMed ID: 2381077
[TBL] [Abstract][Full Text] [Related]
17. IL-3 and ribavirin induce differentiation and growth suppression during long-term treatment of a megakaryocytic leukemia cell line.
Majumdar A; Kerby S; Mullikin B; Beckstead JH; Stenberg PE; Seidman MM
J Cell Physiol; 1995 Dec; 165(3):530-7. PubMed ID: 7593232
[TBL] [Abstract][Full Text] [Related]
18. Detection of platelet-specific protein mRNAs in different megakaryoblasts using the reverse transcriptase polymerase chain reaction.
Yasunaga M; Ryo R; Sugano W; Yamaguchi N
Leuk Lymphoma; 1992 Aug; 7(5-6):505-10. PubMed ID: 1493450
[TBL] [Abstract][Full Text] [Related]
19. Retroviral mediated gene transfer in megakaryocytic cell lines.
Kiffmeyer WR; Stambrook PJ; Lieberman MA
In Vitro Cell Dev Biol Anim; 1994 Nov; 30A(11):803-9. PubMed ID: 7881634
[TBL] [Abstract][Full Text] [Related]
20. Antisense BCR-ABL oligomers cause non-specific inhibition of chronic myeloid leukemia cell lines.
O'Brien SG; Kirkland MA; Melo JV; Rao MH; Davidson RJ; McDonald C; Goldman JM
Leukemia; 1994 Dec; 8(12):2156-62. PubMed ID: 7808004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
